title: [Dominant negative activity of mutated p53 proteins].
abstract: Tumor suppressor gene inactivation as proposed by the Knudson model implies a sequential inactivation of two alleles of a gene. For example, the first allele is inactivated by a missense mutation, and the second one is inactivated by a deletion or insertion. The alteration of the p53 tumor suppressor gene is far to correspond only to this model. In the great majority of cancers, the mutated allele of p53 coexists with the normal allele. It is well known that the transcriptional activity is one of the most important functions of p53. The p53 protein is active as a tetramer (this complex activates the expression of targeted genes by binding to its consensus DNA sequence called the p53 response element). Experimental evidence shows that wild-type p53 interacts with mutant proteins to form heterotetramers. In association with wild-type proteins, mutant proteins drive the wild-type subunits into a mutant conformation. This association leads to a loss of trans-activating function. The capacity of mutant subunits to form heterotetramers with wild-type subunits and to commit them into a mutant conformation is called << dominant negative effect >>. Many p53 mutant proteins possess this dominant negative activity. Recently, several factors, which are implicated in the control of the dominant negative activity of p53 mutants, have been identified. The elucidation of these complex molecular functions, which are implicated in the dominant negative activity of the p53 mutated protein represents an important aspect in the comprehension of the biological mechanisms involved in carcinogenesis.
authors.affiliation: Service de Génétique, Département de Pédiatrie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 3001, 12e avenue Nord, Sherbrooke (Québec), J1H 5N4, Canada.
authors.forename: Walid
authors.initials: W
authors.lastname: Dridi
authors.forename: Kada
authors.initials: K
authors.lastname: Krabchi
authors.forename: Macoura
authors.initials: M
authors.lastname: Gadji
authors.forename: Josée
authors.initials: J
authors.lastname: Lavoie
authors.forename: Marc
authors.initials: M
authors.lastname: Bronsard
authors.forename: Raouf
authors.initials: R
authors.lastname: Fetni
authors.forename: Régen
authors.initials: R
authors.lastname: Drouin
mesh_terms: D005799:Genes, Dominant; D006801:Humans; D008958:Models, Molecular; D009154:Mutation; D009369:Neoplasms / Q000235:genetics; D011487:Protein Conformation; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000235:genetics*
chemical_list: D016159:Tumor Suppressor Protein p53